Fampyra Evrópusambandið - pólska - EMA (European Medicines Agency)

fampyra

biogen netherlands b.v.  - fampridine - stwardnienie rozsiane - inne leki na układ nerwowy - produkt leczniczy fampyra jest wskazany w leczeniu chodzenia u dorosłych pacjentów ze stwardnieniem rozsianym, z chodzeniem niepełnosprawności (rozszerzona skala 4-7).

Zeposia Evrópusambandið - pólska - EMA (European Medicines Agency)

zeposia

bristol-myers squibb pharma eeig - ozanimod chlorowodorek - multiple sclerosis, relapsing-remitting; colitis, ulcerative - leki immunosupresyjne - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.

Fampridine Accord Evrópusambandið - pólska - EMA (European Medicines Agency)

fampridine accord

accord healthcare s.l.u. - fampridine - stwardnienie rozsiane - inne leki na układ nerwowy - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).

Dimethyl fumarate Mylan Evrópusambandið - pólska - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - fumaran dimetylu - stwardnienie rozsiane, Рецидивно-znika - leki immunosupresyjne - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Evrópusambandið - pólska - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - fumaran dimetylu - stwardnienie rozsiane, Рецидивно-znika - leki immunosupresyjne - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Teva Evrópusambandið - pólska - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - fumaran dimetylu - multiple sclerosis, relapsing-remitting; multiple sclerosis - leki immunosupresyjne - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord Evrópusambandið - pólska - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - fumaran dimetylu - multiple sclerosis, relapsing-remitting; multiple sclerosis - leki immunosupresyjne - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).